THROMBOPOIETIN UP-REGULATES THE PROMOTER CONFORMATION OF P53 IN A PROLIFERATION-INDEPENDENT MANNER COINCIDENT WITH A DECREASED EXPRESSION OF BAX - POTENTIAL MECHANISMS FOR SURVIVAL ENHANCING EFFECTS
A. Ritchie et al., THROMBOPOIETIN UP-REGULATES THE PROMOTER CONFORMATION OF P53 IN A PROLIFERATION-INDEPENDENT MANNER COINCIDENT WITH A DECREASED EXPRESSION OF BAX - POTENTIAL MECHANISMS FOR SURVIVAL ENHANCING EFFECTS, Blood, 90(11), 1997, pp. 4394-4402
Thrombopoietin (Tpo) has proliferative and maturational effects on imm
ature and more committed cells, respectively. We previously reported a
role for Tpo as a survival factor in the factor-dependent human cell
line M07e by demonstrating that Tpo suppresses apoptosis in the absenc
e of induced proliferation. Wild-type p53 is a tumor suppressor gene t
hat can play a vital role in mediating growth factor withdrawal-induce
d apoptosis in factor-dependent hematopoietic cells, Wild-type p53 can
switch from a suppressor conformation, with an antiproliferative, pro
-apoptotic phenotype, to a promoter conformation that has a diminished
ability to mediate cell cycle arrest and apoptosis. In an effort to e
lucidate the mechanisms through which Tpo suppresses apoptosis, we inv
estigated the effects of Tpo treatment on p53-mediated apoptosis in M0
7e cells. Tpo upregulated the expression of the promoter conformation
of p53 in M07e cells coincident with a downregulation of Bar and Mdm2
protein levels. Protein levels of Bcl-2 and Bcl-x(L) did not significa
ntly vary as a function of growth-factor stimulation. Conversely, the
levels of suppressor conformation p53 were maximal when M07e was in a
growth arrested state and decreased during factor stimulation. Further
more, Tpo treatment induced an extranuclear buildup and greatly weaken
ed the DNA binding capacity of p53. p53-specific antisense oligonucleo
tide treatment recapitulated the effects of Tpo treatment on the level
s of Bar, Mdm-2, and Bcl-2. These results suggest that Tpo is suppress
ing growth factor withdrawal induced-apoptosis, at least in part, by d
ownregulating the expression of pro-apoptotic Bar protein levels, thro
ugh modulating the conformation of p53, which results in a functional
inactivation of its pro-apoptotic abilities. (C) 1997 by The American
Society of Hematology.